Dear STIRF
Dear STIRF
STIRF will not be advertising for PhD studentships for the academic year 2020-21
We invite researchers in various fields related to sexual health, HIV and other sexually transmitted viruses to apply for research funds.
Sexually Transmitted Infections Research Foundation (STIRF) was set up to pump prime research projects relating to the epidemiology, pathophysiology, management, and health care delivery of sexually transmitted infections and HIV in the West Midlands, Trent, Yorkshire, Northern and North West regions.
The primary aim is to provide initial funding to allow promising projects from researchers early in their career to obtain preliminary results as a prelude to acquire further funds from larger funding bodies.
We invite applications from researchers in the above regions on projects relating to sexually transmitted diseases and HIV. All projects will be initially screened by the Scientific Committee of STIRF and those considered suitable will be sent for peer review by experts in the field.
The following fields of research will be considered in relation to STIs and HIV
Applications should not exceed £50,000 in the first year. Depending on satisfactory reports a further £25,000 may be available for the second year. Joint funding with other grant giving bodies will be considered.
For further information and guidance on how to apply visit
https://stirf.org/application-for-research-funds-from-stirf/
Applications using the appropriate form downloaded from the STIRF web site should be sent with a short CV of the lead investigator by email to:
Dr Mohsen Shahmanesh, (Hon Secretary STIRF)
Stirfweb@gmail.com
The Sexually Transmitted Infection Research Foundation (STIRF) is a local charity which supports research relating to all aspects of sexual health including clinical practice, public health, microbiology, health economics and behavioural science.
STIRF wishes to fund a PhD Studentship up to a maximum of £60 000 over 3-4 years and is inviting applications with a closing date of February 29, 2020.(see below)
Applications would only be considered from universities in the following UK health regions:
West Midlands, Trent, Yorkshire, Northern and North West regions
For details of how to apply go to:
The Sexually Transmitted Infection Research Foundation (STIRF) is a local charity which supports research relating to all aspects of sexual health including clinical practice, public health, microbiology, health economics and behavioural science.
STIRF wishes to fund a PhD Studentship up to a maximum of £60 000 over 3-4 years and is inviting applications with a closing date of July 31, 2018.
Applications would only be considered from universities in the following UK health regions:
West Midlands, Trent, Yorkshire, Northern and North West regions
For details of how to apply go to:
In the latest issue of the Sexually Transmitted Infections, Phillip Hay and colleagues in the UK report on a prospective study of female students attending 11 universities and 9 further education colleges in London.
At the start, the students were asked to fill a questionnaire and provide a self taken vaginal sample for infection screening. After 12 months, they were assessed for pelvic inflammatory disease (PID), a condition that can lead to infertility and other complications.
PID was found in 1.6% of the particpants. Unsurprisingly the strongest predictor of PID was the presence of Chlamydia trachomatis at the first visit (relative risk (RR) 5.7).
However, adjusting for this, the authors reported that significant predictors of PID were ≥2 sexual partners (RR 4.0) or a new sexual partner during follow-up (RR 2.8), and age <20 years (RR 3.3). Somewhat surprisingly recruitment from a further education college rather than a university also increased the relative risk of PID 2.6 fold, perhaps reflecting different health protection behaviors (eg condom use) between the two groups.
The study concluded that in addition to known risk factors such as multiple or new partners in the last 12 months and younger age, attending a further education college rather than a university were risk factors for PID.
They recommended that sexual health education and screening programs could be targeted at these high-risk groups.
Daily HIV medicine taken by men who have sex with men (MSM) reduces risk of HIV infection by 86% as was reported by Molina J-M, and colleagues in the ANRS Ipergay trial at the Conference on Retroviruses and Opportunistic Infections held in Seattle, USA in 2015 (23LB.).
Molina et al reported the final results of a three year study which randomised MSM who were negative for HIV to either take daily HIV prophylaxis with two anti-retroviral drugs in a single tablet immediately or deferred for 1 year.
The study showed that those taking the drugs on a daily basis have a 86% reduction in the risk of being infected by HIV than MSM not taking the drug (p=0.0001). The trial was stopped in October of 2014 and all participants in the deferred group were offered pre-exposure prophylaxis (PrEP)
As a Lancet editorial commented:
The science is now clear: oral pre-exposure prophylaxis (PrEP) with a coformulation of tenofovir disoproxil fumarate and emtricitabine (Truvada) significantly reduces the risk of HIV infection among individuals at high risk of HIV infection.
The news that PrEP has shown consistent efficacy among those who take it as prescribed should be a cause for celebration, and galvanise action to ensure access to PrEP for those who could benefit the most. But almost 3 years since the US Food and Drug Administration approved tenofovir–emtricitabine for PrEP little is being done on implementation.
With more than 2 million new HIV infections every year worldwide, it is time for that to change.
A workshop on philosophical aspects of sexual health is being held at
Seminar Room 3.28, New Business School, Manchester Metropolitan University Manchester, United Kingdom
The workshop is run by Dr Phil Hutchinson and was part funded by a research grant from Sexually Transmitted Infections Research Foundation (STIRF). Project STIRF-026
Workshop 1: The Problem of Selection Bias in Biomedical & Public Health Research. Wednesday September 16
Workshop 2: Shame, Stigma and HIV. Thursday September 17
Venue: Seminar Room 3.28, New Business School, Manchester Metropolitan University, Manchester, UK
Mandatory registration: contact: marie.chollier@stu.mmu.ac.uk
Further information can be obtained from Phil Hutchinson p.hutchinson@mmu.ac.uk
A new project funded by STIRF (STIRF-027) has just been completed.
Background: In the United Kingdom there is an established and growing refugee population from Somalia. Despite this Somalis have remained absent from much of the official statistics largely because ‘Somali’ is rarely recognised as a distinct ethnic category. Little is known about the sexual health needs of this particular community but in terms of their broader health issues, Somalis are known to have a high level of need but low uptake of health care services (Carswell et al.2011).
Aims: Through the use of focus groups and individual interviews this study sought to explore the sexual health needs of the local Somali community by ascertaining from their perspective, what they know about sexual health services, the challenges that may prevent them taking up these services and how services could be adapted to best meet their needs.
Results: The study showed little knowledge of services, especially about sexual health, how to accessing services, issues relating to shame, stigma and taboo, the influence of gender, religious and cultural norms, the perceptions of young people, the language barrier lack of cultural awareness and sensitivity demonstrated by healthcare professionals.
Recommendations:
The results of the study have been presented in international meetings and published in reputable international journals.
The US based Centre for disease control (CDC) has recently updated its factsheet on lesbian and bisexual health. The CDC emphasises the potential risks of acquiring sexually transmitted infections and HIV from certain sexual practices. The article provides advise on how lesbian and bisexual women can protect themselves.